Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Assets (2023 - 2025)

Camp4 Therapeutics' Non-Current Assets history spans 3 years, with the latest figure at -$114.1 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 1056.85% year-over-year to -$114.1 million; the TTM value through Dec 2025 reached -$138.0 million, changed N/A, while the annual FY2025 figure was -$114.1 million, 1056.85% down from the prior year.
  • Non-Current Assets for Q4 2025 was -$114.1 million at Camp4 Therapeutics, down from -$51.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $15.9 million in Q3 2024 and bottomed at -$114.1 million in Q4 2025.
  • The 3-year median for Non-Current Assets is $11.9 million (2024), against an average of -$24.6 million.
  • The largest annual shift saw Non-Current Assets decreased 20.15% in 2024 before it tumbled 1056.85% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $14.9 million in 2023, then fell by 20.15% to $11.9 million in 2024, then crashed by 1056.85% to -$114.1 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Non-Current Assets are -$114.1 million (Q4 2025), -$51.7 million (Q1 2025), and $11.9 million (Q4 2024).